Rss Feed

Smoking even 2-5 cigarettes a day can more than double your risk of any type of heart disease and raise your risk of death from any cause by 60% compared to people who never smoked, according to new research supported by the American Heart Association's Tobacco Center for Regulatory Science and published in PLOS Medicine.

A study published in the Journal of Patient Experience, with the participation of the D'Or Institute for Research and Education (IDOR), analyzed the perceptions of over 47,000 healthcare professionals on institutional efforts to improve patient experience in private hospitals in Brazil.

Cow’s milk allergy rarely causes infant colic on its own, and most excessively crying infants do not have underlying allergy. A short elimination–and–rechallenge trial may help confirm CMA only when colic coexists with other allergic features.

MPFI Scientists have discovered how two brain areas work together like an hourglass to flexibly control movement timing.

Parents may have more influence than they realize when it comes to shaping their children's behavior, especially for those at higher genetic risk for conduct problems, according to Rutgers Health-led research.

A blood pressure as low as 120/80 mm Hg in adolescence can be linked to a higher risk of atherosclerosis in middle age, according to a study led from Linköping University, Sweden.

A newly developed tool, called the DILI-Inpt prognostic score, can predict patients with drug-induced liver injury who are unlikely to survive without a liver transplant.

Researchers at the Victor Chang Cardiac Research Institute, University of Sydney, and the Royal Hospital for Women have uncovered important new insights into the biology of recurrent miscarriage - a devastating condition that affects up to one in fifty couples trying to conceive.

The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it.

Mental health problems are keeping an increasing number of Norwegians out of the employment market. Treatment alone is often not enough to get people back to work.

Jennifer Munson, a cancer researcher at Virginia Tech's Fralin Biomedical Research Institute at VTC, has been awarded two new National Institutes of Health grants to advance greater understanding and improved treatment of a deadly brain cancer.

Middle-aged Australians are keeping the country running - but it's taking a hefty toll on their wellbeing, a new report shows.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss and behavioral disturbances that severely impair quality of life. Despite decades of research, effective disease-modifying therapies remain elusive, underscoring the urgent need for novel neuroprotective strategies.

Eating moderate amounts of lean beef as part of a Mediterranean diet does not increase an emerging risk factor for cardiovascular disease, according to a new study by an interdisciplinary research team at Penn State.

Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can cause dangerously high cholesterol and early heart disease, a Mayo Clinic study found.

Pertussis, or whooping cough, remains a highly contagious respiratory infection caused by Bordetella pertussis. Despite inclusion of pertussis vaccines in immunization programs since the 1970s, outbreaks have re-emerged globally due to waning immunity and bacterial evolution.

Garlic extract demonstrates antimicrobial efficacy comparable to other widely used antiseptics and disinfectants, such as chlorhexidine, according to University of Sharjah medical scientists.

"Drains" in the brain, responsible for clearing toxic waste in the organ, tend to get clogged up in people who show signs of developing Alzheimer's disease, a study by researchers from Nanyang Technological University, Singapore (NTU Singapore) has discovered.

An international research group directed by UMC Utrecht have developed and characterized two first-in-class antibodies that specifically block the high-affinity IgG receptor FcγRI.

Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications.